Mike McCormick

Mike McCormick serves as President, CEO, and Board Member at CorRen Medical, Inc., focusing on the development of UltraSense, an innovative ultrasound test for Peripheral Artery Disease. Additionally, McCormick holds roles as Board Member and Lead Independent Director at Nuwellis, Inc., which aims to enhance patient care for heart failure. With a longstanding commitment to advancing medical technology, McCormick has contributed to various companies, including Osprey Medical, where a first-to-market device for reducing kidney injury during angiography was successfully commercialized. McCormick's extensive experience encompasses leadership positions in multiple medical device firms, including Anulex Technologies, Centerpulse SpineTech, and Boston Scientific, and includes a solid educational foundation with degrees in management from The University of Texas at Austin and experience as a guest lecturer on medical device leadership at the University of Minnesota.